DCBY02 is a pioneering humanized IgG1 monoclonal antibody specifically developed to target CD93. This antibody is engineered to normalize tumor vasculature, thereby enhancing the infiltration of immune cells into the tumor microenvironment. Its mechanism promotes the efficacy of concurrent cancer immunotherapies, making it a valuable tool for advancing oncological research and therapeutic development.
DCBY02 is a pioneering humanized IgG1 monoclonal antibody specifically developed to target CD93. This antibody is engineered to normalize tumor vasculature, thereby enhancing the infiltration of immune cells into the tumor microenvironment. Its mechanism promotes the efficacy of concurrent cancer immunotherapies, making it a valuable tool for advancing oncological research and therapeutic development.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: